BiotechTube

TBP-PI-HBr + Imipenem-cilastatin + Dummy Infusion + Dummy Tablets

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Urinary Tract Infection

Conditions

Urinary Tract Infection, Acute Pyelonephritis

Trial Timeline

Dec 21, 2023 → Feb 6, 2025

NCT ID
NCT06059846

About TBP-PI-HBr + Imipenem-cilastatin + Dummy Infusion + Dummy Tablets

TBP-PI-HBr + Imipenem-cilastatin + Dummy Infusion + Dummy Tablets is a phase 3 stage product being developed by Spero Therapeutics for Urinary Tract Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT06059846. Target conditions include Urinary Tract Infection, Acute Pyelonephritis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT06059846Phase 3Completed

Competing Products

20 competing products in Urinary Tract Infection

See all competitors
ProductCompanyStageHype Score
Duloxetine + placeboEli LillyPhase 2
52
DuloxetineEli LillyPhase 2
52
Enfortumab vedotinAstellas PharmaPhase 1
33
solifenacin succinate + tamsulosin + placeboAstellas PharmaApproved
85
solifenacin succinate + tamsulosin hydrochloride + Placebo to solifenacin + Placebo to tamsulosinAstellas PharmaPhase 2
52
SolifenacinAstellas PharmaApproved
85
Mirabegron + Tolterodine + Placebo to Mirabegron + Placebo to TolterodineAstellas PharmaPhase 3
77
Levofloxacin + Solifenacin succinate + Placebo (for Solifenacin succinate)Astellas PharmaApproved
85
solifenacin succinateAstellas PharmaPhase 3
77
SolifenacinAstellas PharmaPre-clinical
23
SolifenacinAstellas PharmaPre-clinical
23
TamuslosinAstellas PharmaPhase 3
77
Tamsulosin + SolifenacinAstellas PharmaApproved
85
Alpha blocker + placebo + solifenacinAstellas PharmaApproved
85
mirabegron 25 mg + mirabegron 50 mg + solifenacin 5 mg + solifenacin 10 mg + mirabegron 25 mg matching placebo + mirabegron 50 mg matching placebo + solifenacin 5 mg matching placebo + solifenacin 10 mg matching placeboAstellas PharmaPhase 3
77
solifenacin succinate + tolterodineAstellas PharmaPhase 3
77
TamusulosinAstellas PharmaPhase 3
77
SolifenacinAstellas PharmaPre-clinical
23
Solifenacin succinate + TolterodineAstellas PharmaPhase 3
77
Solifenacin succinate + PlaceboAstellas PharmaPhase 3
77

Other Products from Spero Therapeutics

TBPM-PI-HBr + Ertapenem + Dummy Infusion + Dummy tabletsPhase 3
69
SPR720 + Placebo + Open-label Standard of CarePhase 2
44
Placebo + SPR720 500 mg + SPR720 1000 mgPhase 2
44
SPR994 + Placebo Oral Tablet + Orapenem®Phase 1
25
TBPM-PI-HBrPhase 1
25